₹104.00
−5.37%BSE close, 16 Nov 2026
−26.89%
EARKART is a small cap company in the Healthcare sector, listed on BSE SME under the symbol EARKART (BSE code 544549). At ₹104.00 a share, the market values the whole company at ₹143 crore. BSE SME is the exchange's platform for small and medium companies, which report their results every half year.
Over the past year the share price has fallen 56.4%, and it is 57.2% below its 52-week high.
Companies of a similar size in the same sector include GUJARAT INJECT (KERALA), AURO LABORATORIES, PANCHSHEEL ORGANICS and ASSTON PHARMACEUTICALS.
Listed on BSE SME, the platform for small and medium companies: its shares trade in large lots and often thinly, so the price can move sharply on a few trades, and companies file results every half year.
This company is listed only on BSE, so its page shows price figures only: results and shareholding on RupeeVerse come from companies’ NSE filings.
The same sector (Healthcare), nearest in size.
| Company | Price | Market cap | P/E | ROE | Sales growth | 1Y |
|---|---|---|---|---|---|---|
| EARKART | ₹104.00 | ₹143 cr | n/a | n/a | n/a | −56.37% |
| GUJARAT INJECT (KERALA) | ₹10.40 | ₹152 cr | n/a | n/a | n/a | +317.84% |
| AURO LABORATORIES | ₹235.10 | ₹147 cr | n/a | n/a | n/a | +25.86% |
| PANCHSHEEL ORGANICS | ₹107.30 | ₹141 cr | n/a | n/a | n/a | −22.25% |
| ASSTON PHARMACEUTICALS | ₹165.25 | ₹141 cr | n/a | n/a |
| +106.56% |
| Aspira Pathlab & Diagnostics L | ₹131.00 | ₹135 cr | n/a | n/a | n/a | +118.33% |
|---|
| GODAVARI DRUGS | ₹123.35 | ₹135 cr | n/a | n/a | n/a | +47.53% |
|---|
| SPECIALITY MEDICINES | ₹153.00 | ₹134 cr | n/a | n/a | n/a | n/a |
|---|
| CHOKSI LABORATORIES | ₹189.25 | ₹132 cr | n/a | n/a | n/a | +32.81% |
|---|